Last reviewed · How we verify

NCT05768217

Community Resiliency Collective Efficacy Intervention

Recruiting now NA Last updated 8 July 2025
What this trial tests

NA trial testing Community Resiliency Collective Efficacy Intervention (CRCEI) in Violence, Physical in 4,600 participants. Currently enrolling.

Timeline
24 June 2024
Primary endpoint
30 September 2026
30 September 2027

Quick facts

Lead sponsorUniversity of Pittsburgh
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment4,600
Start date24 June 2024
Primary completion30 September 2026
Estimated completion30 September 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pittsburgh

Who can join

13 and older, any sex, with Violence, Physical or Violence, Non-accidental. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate, via a cluster-randomized controlled trial, the effectiveness of a community-centered intervention that promotes thriving and resiliency to reduce community violence.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Violence, Physical

Currently open trials in the same condition.

Other University of Pittsburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05768217.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing